Mitochondrial electron transport chain (Complex I-IV) (ETC)

The mitochondrial electron transport chain (ETC), comprising Complexes I through IV, is a series of multi-protein enzyme complexes located in the inner mitochondrial membrane that facilitates oxidative phosphorylation [2, 7]. Its primary biological function is to transfer electrons from donors such as NADH and FADH2 to molecular oxygen, the terminal electron acceptor, while simultaneously pumping protons across the membrane to establish an electrochemical gradient [16, 23]. This gradient provides the proton-motive force necessary for ATP synthase (Complex V) to generate ATP, the cell's primary energy currency [14, 22]. Beyond bioenergetics, the ETC is a major site of reactive oxygen species (ROS) production and acts as a key regulator of the intrinsic apoptosis pathway and cellular redox homeostasis [7, 18]. Dysregulation of these complexes is central to the pathogenesis of primary mitochondrial disorders, such as Leigh syndrome and MELAS, and is implicated in neurodegenerative diseases, cardiovascular conditions, and metabolic syndrome [2, 19, 21]. Pharmacologically, the ETC is targeted by a variety of agents: Metformin inhibits Complex I to modulate metabolic pathways in diabetes, while experimental 'mitocans' target the ETC to induce apoptosis in cancer cells by increasing ROS or depleting ATP [20, 21, 24]. However, therapeutic intervention is challenging due to the risk of severe safety concerns, including lactic acidosis and systemic mitochondrial toxicity [4, 13].

Other names

Respiratory chainOxidative phosphorylation systemOXPHOSMitochondrial respiratory chainElectron transport systemETS

Inhibition of electron transfer within specific complexes, uncoupling of the proton gradient from ATP synthesis, modulation of reactive oxygen species (ROS) production, and enhancement of electron flow via bypass mechanisms [9, 20, 21].